Quebec-based pharmaceutical company takes its hostile $50.8 billion bid directly to shareholders
US drugmaker raises offer for British rival to £50 a share or £63 billion after earlier bid was rebuffed
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices